Stroke

Showing NaN - NaN of 37

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Stroke, Cerebral Infarction, Brain Diseases Trial in Canada (Arm Boot Camp)

Completed
  • Stroke
  • +10 more
  • Arm Boot Camp
  • Calgary, Alberta, Canada
  • +6 more
Feb 1, 2023

Stroke, Patent Foramen Ovale Trial in Canada, United States (AMPLATZER™ PFO Occluder)

Recruiting
  • Stroke
  • Patent Foramen Ovale
  • AMPLATZER™ PFO Occluder
  • Birmingham, Alabama
  • +90 more
Jan 30, 2023

Stroke, Cerebrovascular Accident, Cerebral Infarction Trial in Canada (drug, other, behavioral)

Active, not recruiting
  • Stroke
  • +9 more
  • Fluoxetine Hydrochloride
  • +2 more
  • Calgary, Alberta, Canada
  • +7 more
May 18, 2022

Stroke Trial in Canada, United States (Apixaban, Aspirin)

Recruiting
  • Stroke
  • Birmingham, Alabama
  • +181 more
Mar 26, 2022

Atrial Fibrillation, Stroke Trial in Worldwide (Rivaroxaban, Acetylsalicylic acid)

Recruiting
  • Atrial Fibrillation
  • Stroke
  • Canberra, Australian Capital Territory, Australia
  • +54 more
Mar 23, 2022

Coronary Disease, Stroke, Chronic Kidney Disease Trial in Calgary (Copayment Elimination, Personalized Education)

Completed
  • Coronary Disease
  • +6 more
  • Copayment Elimination
  • Personalized Education
  • Calgary, Alberta, Canada
    University of Calgary
Mar 2, 2022

s of Motor Learning During Stroke Neurorehabilitation

Recruiting
  • Stroke
  • Magnetic Resonance Imaging (MRI)
  • +2 more
  • Calgary, Alberta, Canada
  • +3 more
Nov 2, 2021

Atrial Fibrillation, Stroke Trial in Worldwide (Apixaban, aspirin)

Active, not recruiting
  • Atrial Fibrillation
  • Stroke
  • Mesa, Arizona
  • +129 more
Aug 25, 2021

Stroke Trial in Calgary (Axem Home Prototype Device, Rehabilitation Exercise Program)

Not yet recruiting
  • Stroke
  • Axem Home Prototype Device
  • Rehabilitation Exercise Program
  • Calgary, Alberta, Canada
    Calgary Stroke Program Early Supported Discharge
Aug 16, 2021

Stroke, Aphasia, Non-fluent Trial in Calgary (1Hz inhibitory rTMS, Multi-Modality Aphasia Therapy (M-MAT), 1Hz sham rTMS)

Completed
  • Stroke
  • Aphasia, Non-fluent
  • 1Hz inhibitory rTMS
  • +2 more
  • Calgary, Alberta, Canada
    Foothills Medical Centre
May 26, 2021

GLORIA-AF Registry Program - Second and Third Phases

Completed
  • Stroke
  • Atrial Fibrillation
    • Mobile, Alabama
    • +665 more
    Mar 3, 2021

    Stroke, Atrial Fibrillation, Arrhythmias, Cardiac Trial in Calgary, Edmonton (Medtronic Reveal LINQ, Sorin Spiderflash-t)

    Completed
    • Stroke
    • +2 more
    • Medtronic Reveal LINQ
    • Sorin Spiderflash-t
    • Calgary, Alberta, Canada
    • +2 more
    Nov 6, 2020

    Stroke Trial in Calgary (Robotic exoskeleton, Usual Care)

    Recruiting
    • Stroke
    • Robotic exoskeleton
    • Usual Care
    • Calgary, Alberta, Canada
      Foothills Hospital
    Dec 19, 2019

    Cerebrovascular Accident, Stroke, Cerebral Infarction Trial in Canada (Stroke Management Program (SMP), Stroke Monitoring

    Completed
    • Cerebrovascular Accident
    • +9 more
    • Stroke Management Program (SMP)
    • +2 more
    • Calgary, Alberta, Canada
    • +7 more
    Dec 12, 2019

    Stroke, Secondary Prevention Trial in Worldwide (optional ASA as comedication, to ASA, to optional ASA as comedication)

    Completed
    • Stroke
    • Secondary Prevention
    • optional ASA as comedication
    • +5 more
    • Phoenix, Arizona
    • +568 more
    Aug 13, 2019

    Atrial Fibrillation, Stroke Trial in Worldwide (warfarin, Dabigatran dose 1, Dabigatran dose 2)

    Completed
    • Atrial Fibrillation
    • Stroke
    • Birmingham, Alabama
    • +983 more
    Apr 8, 2019

    Stroke Trial in Calgary (1x1 anodal tDCS, Sham tDCS, Robotic Rehabilitation)

    Unknown status
    • Stroke
    • 1x1 anodal tDCS
    • +2 more
    • Calgary, Alberta, Canada
      Stroke Robotic and Recovery Lab, Foothills Medical Centre
    Mar 20, 2019

    Stroke, Atrial Fibrillation, Embolism Trial in Worldwide (warfarin tablets, Edoxaban tablets (high dose regimen-60mg), Edoxaban

    Completed
    • Stroke
    • +2 more
    • warfarin tablets
    • +4 more
    • Birmingham, Alabama
    • +1015 more
    Feb 8, 2019

    Stroke Trial in Worldwide (Rivaroxaban (Xarelto, BAY59-7939), Acetylsalicylic acid (Aspirin, BAY1019036), Rivaroxaban-Placebo)

    Terminated
    • Stroke
    • Rivaroxaban (Xarelto, BAY59-7939)
    • +3 more
    • Tucson, Arizona
    • +453 more
    Dec 20, 2018

    Stroke, Transient Ischemic Attack, Atrial Fibrillation Trial in Canada (a 30-day ambulatory cardiac event monitor, 24-hour

    Unknown status
    • Stroke
    • +3 more
    • a 30-day ambulatory cardiac event monitor
    • 24-hour Holter
    • Calgary, Alberta, Canada
    • +16 more
    Oct 3, 2018

    Stroke Trial in Canada (rfVIIa, Standard saline solution)

    Completed
    • Stroke
    • rfVIIa
    • Standard saline solution
    • Calgary, Alberta, Canada
    • +14 more
    Oct 3, 2018

    Stroke Trial in Canada, United States (Tissue plasminogen activator (Activase®))

    Terminated
    • Stroke
    • Tissue plasminogen activator (Activase®)
    • Palo Alto, California
    • +14 more
    Apr 26, 2018

    Atherosclerosis, Stroke, Carotid Stenosis Trial in Canada, United States (Carotid Endarterectomy (CEA), Carotid Artery Stenting

    Completed
    • Atherosclerosis
    • +4 more
    • Carotid Endarterectomy (CEA)
    • Carotid Artery Stenting (CAS)
    • Birmingham, Alabama
    • +114 more
    Apr 13, 2017

    Stroke Trial in Worldwide (Desmoteplase, Placebo)

    Terminated
    • Stroke
    • Phoenix, Arizona
    • +151 more
    Feb 8, 2017

    Stroke Trial in Worldwide (Aggrenox, Clopidogrel , Micardis)

    Completed
    • Stroke
    • Birmingham, Alabama
    • +666 more
    Apr 22, 2014